The Absence of CD44 Ameliorates Fas^lpr/lpr Disease

References

• Jallmnen, S., Bargatze, RE, De Los Toyos, J. and Butcher, E.C. (1987) "Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95 kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal or synovial endothelial cells", J. Cell. Biol. 105, 983–990
   PubMedGoogle Scholar
• Streeter, P.R., Berg, EL., Rouse, B.T., Bargatze, R.F. and Butcher, E.C. (1988) "A tissue-specific endothelial cell molecule involved in lymphocyte homing", Nature 331, 41–46
   PubMedGoogle Scholar
• Arch, R., Wirth, K., Hofmann, M., Ponta, H., Matzku, S., Herrlich, P. and Zoeller, M. (1992) "Participation in normal immune responses of a metastasis-inducing splice variant of CD44", Science 257, 682–685
   PubMed Web of Science ®Google Scholar
• Haynes, B.F., Telen, M.J., Hale, L.P. and Denning, S.M. (1989) "CD44—a molecule involved in leukocyte adherence and T-cell activation", Immunol. Today 10, 423–428
   PubMedGoogle Scholar
• Weber, G.F., Ashkar, S., Glimcher, M.J. and Cantor, H. (1996) "Receptor—ligand interaction between CD44 and osteopontin (Eta-1)", Science 271, 509–512
   PubMed Web of Science ®Google Scholar
• Ashkar, S., Weber, G.F., Panoutsakopoulou, V., Sanchirico, Janssen, M., Zawaideh, S., Riffling, S., Denhardt, D.T., Glimcher, M.J. and Cantor, H. (2000) "Eta-1 (Osteopontin): an early component of type 1 (cell-mediated) immunity", Science 287, 860–864
   PubMed Web of Science ®Google Scholar
• Fujii, K., Fujii, Y., Hubscher, S. and Tanaka, Y. (2001) "CD44 is the physiological trigger of Fas up-regulation on rheumatoid synovial cells", J. Immunol. 167, 1198–1203
   PubMedGoogle Scholar
• Yasuda, M., Tanaka, Y., Fujii, K. and Yasumoto, K. (2001) "CD44 stimulation down-regulates Fas expression and Fas-mediated apoptosis of lung cancer cells", Int. Immunol. 13, 1309–1319
   PubMedGoogle Scholar
• Lisignoli, G., Grassi, F., Zini, N., Toneguzzi, S., Piacentini, A., Guidolin, D., Bevilacqua, C. and Facchini, A. (2001) "Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: evidence for CD44 and CD54 (intercellular adhesion molecule 1) involve-ment", Arthritis Rheum. 44, 1800–1807
   PubMed Web of Science ®Google Scholar
• Budd, R.C., Schumacher, J.H., Winslow, G. and Mosmann, T.R. (1991) "Elevated production of interferon-gamma and interleukin 4 by mature T cells from autoimmune lpr mice correlates with Pgp-1 (CD44) expression", Eur. J. Immunol. 21, 1081–1084
   PubMedGoogle Scholar
• Davidson, WE, Calkins, C., Hugins, A., Giese, T. and Holmes, K.L. (1991) "Cytokine secretion by C3H-lpr and -gld T cells. Hypersecretion of IFN-gamma and tumor necrosis factor-alpha by stimulated CD4+ T cells", J. Immunol. 146, 4138–4148
   PubMed Web of Science ®Google Scholar
• Wang, W., Kobayashi, S. and Uede, T. (1992) "Dysregulated expression of cellular adhesion molecules in autoimmune-prone mice", J. DennatoL 19, 831–835
   Google Scholar
• Giese, T. and Davidson, WE (1992) "Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for lpr", J. Immunol. 149, 3097–3106
   PubMedGoogle Scholar
• Katoh, S., McCarthy, J.B. and Kincade, P.W. (1994) "Character-ization of soluble CD44 in the circulation of mice. Levels are affected by immune activity and tumor growth", J. Immunol. 153, 3440–3449
   PubMed Web of Science ®Google Scholar
• Benz, P.S., Fan, X. and Wuethrich, R.P. (1996) "Enhanced tubular epithelial CD44 expression in MRL-lpr lupus nephritis", Kidney Int. 50, 156–163
   PubMedGoogle Scholar
• Schmits, R., Filinus, J., Gerwin, N., Senaldi, G., Kiefer, F., Kundig, T., Wakeham, A., Shahinian, A., Catzavelos, C., Rak, J., Furlonger, C., Zakarian, A., Simard, J.J., Ohashi, PS., Paige, C.J., Gutierrez-Ramos, J.C. and Mak, T.W. (1997) "CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity", Blood 90, 2217–2233
   PubMed Web of Science ®Google Scholar
• Manheimer, A. and Bona, C. (1985) "Age-dependent isotype variation during secondary immune response in MRL/lpr mice producing autoanti-gamma-globulin antibodies", Eur. J. Immunol. 15, 718–722
   PubMedGoogle Scholar
• Stassin, V., Coulie, PG., Birshtein, BK., Secher, D.S. and Van Snick, J. (1983) "Determinants recognized by murine rheumatoid factors: molecular localization using a panel of mouse myeloma variant immunoglobulins", J. Exp. Med. 158, 1763–1768
   PubMed Web of Science ®Google Scholar
• Izui, S., Kelley, V.E., Masuda, K., Yoshida, H., Roths, J.B. and Murphy, ED. (1984) "Induction of various autoantibodies by mutant gene lpr in several strains of mice", J. Immunol. 133, 227–233
   PubMed Web of Science ®Google Scholar
• Kelley, V.E. and Roths, J.B. (1985) "Interaction of mutant lpr gene with background strain influences renal disease", ClM. Immunol. Immunopathol. 37, 220–229
   PubMedGoogle Scholar
• Haegel, H. and Ceredig, R. (1992) "Transcripts encoding mouse CD44 (Pgp-1, Ly-24) antigen: strain variation and induction by mitogen", Eur. J. Immunol. 21, 1549–1553
   Google Scholar
• Cohen, P.L. and Eisenberg, R.A. (1991) "Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease", Ann. Rev. Immunol. 9, 243–269
   PubMed Web of Science ®Google Scholar
• Weber, G.F. and Cantor, H. (2001) "Differential roles of osteopontin/Eta-1 in early and late lpr disease", Clin. Exp. Immunol. 126, 578–583
   PubMedGoogle Scholar
• O'Sullivan, F.X., Vogelweid, CM., Besch-Williford, C.L. and Walker, S.E. (1995) "Differential effects of CD4+ T cell depletion on inflammatory central nervous system disease, arthritis and sialadenitis in MRL/lpr mice", J. Autoimmun. 8, 163–175
   PubMedGoogle Scholar
• Vogelweid, CM., Johnson, G.C., Besch-Williford, CL., Basler, J. and Walker, S.E. (1991) "Inflammatory central nervous system disease in lupus-prone MRL/lpr mice: comparative histologic and immunohistochemical findings", J. NeuroimmunoL 35, 89–99
   PubMedGoogle Scholar
• Pestano, GA., Zhou, Y, Trimble, L.A., Daley, J., Weber, G.F. and Cantor, H. (1999) "Inactivation of misselected CD8 T cells by CD8 gene methylation and cell death", Science 284, 1187–1191
   PubMedGoogle Scholar
• Jevnikar, A.M., Grusby, M.J. and Glimcher, L.H. (1994) "Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice", J. Exp. Med. 179, 1137–1143
   PubMed Web of Science ®Google Scholar
• Mountz, J.D., Smith, HR., Wilder, R.L., Reeves, J.P. and Steinberg, A.D. (1987) "CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production", J. Immunol. 138, 157–163
   PubMed Web of Science ®Google Scholar
• Tutt-Landolfi, MM., van Houten, N., Russel, J.Q., Scollay, R., Parnes, J. and Budd, R.C. (1993) "CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+-CD8+ thymic precursor", J. Immunol. 151, 1086–1096
   PubMedGoogle Scholar
• Mixter, P.F., Russell, J.Q., Dune, F.H. and Budd, R.C. (1995) "Decreased CD4-CD8- TCR± cells in lpr/lpr mice lacking 132-microglobulin", J. Immunol. 154, 2063–2074
   PubMed Web of Science ®Google Scholar
• Ohteki, T., Iwamoto, M., Izui, S. and MacDonald, H.R. (1995) "Reduced development of CD4-8-13220+ T cells but normal autoantibody production in lpr/lpr mice lacking major histocompatibility complex class I molecules", Eur. J. Immunol. 25, 37–41
   PubMedGoogle Scholar
• Merino, R., Fossati, L., Iwamoto, M., Takahashi, S., Lemoine, R., Ibnou-Zekri, N., Pugliatti, L., Merino, J. and Izui, L. (1995) "Effect of long-term anti-CD4 or anti-CD8 treatment on the development of lpr CD4- CD8- double negative T cells and of the autoimmune syndrome in MRL-lprl lpr mice", J. Autoimmun. 8, 33–45
   PubMed Web of Science ®Google Scholar
• Koh, DR., Ho, A., Rahemtulla, A., Fung-Leung, W.P., Griesser, H. and Mak, T.W. (1995) "Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells", Eur. J. Immunol. 25, 2558–2562
   PubMedGoogle Scholar